Factors Associated With Delayed and Late Initiation of Antiretroviral Therapy Among Patients With HIV in Beijing, China, 2010-2020
- PMID: 37416802
- PMCID: PMC10321558
- DOI: 10.3389/ijph.2023.1605824
Factors Associated With Delayed and Late Initiation of Antiretroviral Therapy Among Patients With HIV in Beijing, China, 2010-2020
Abstract
Objectives: To determine factors associated with late and delayed antiretroviral therapy (ART) initiation in China and provide evidence for HIV prevention. Methods: Logistics regression model was used to determine factors associated with three outcomes: late (CD4 cell count <200 cells/µL or clinical AIDS diagnosis prior to ART initiation), delayed (more than 1 month between HIV diagnosis date and ART initiation) and either late or delayed ART initiation. Results: Multivariable analysis revealed that male, heterosexual, HIV diagnosis before 2014, HBV/HCV seropositive, and tuberculosis were associated with increased odds of all three outcomes. Conversely, married or cohabiting patients were less likely to have delayed ART initiation and either late or delayed ART initiation, while people who inject drugs were more likely to have these two outcomes. Additionally, older age was associated with an increased risk of having either late or delayed ART initiation, but a decreased risk of delayed ART initiation. Conclusion: The proportion of late and delayed ART initiation decreased significantly after the release of the 2016 guidelines in China. To further improve late diagnosis and early treatment, precise interventions for key populations are required.
Keywords: CD4; China; HIV; antiretroviral therapy; associated factors.
Copyright © 2023 Mi, Zhou, Zeng, Wang, Gao and Cheng.
Conflict of interest statement
The authors declare that they do not have any conflicts of interest.
Similar articles
-
Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.J Int AIDS Soc. 2014 Mar 14;17(1):18804. doi: 10.7448/IAS.17.1.18804. eCollection 2014. J Int AIDS Soc. 2014. PMID: 24598459 Free PMC article.
-
Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.AIDS. 2015 Jan 2;29(1):67-76. doi: 10.1097/QAD.0000000000000520. AIDS. 2015. PMID: 25562492 Free PMC article.
-
Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study.BMC Infect Dis. 2017 Apr 19;17(1):285. doi: 10.1186/s12879-017-2398-5. BMC Infect Dis. 2017. PMID: 28420350 Free PMC article.
-
Prevalence of delayed antiretroviral therapy initiation among people living with HIV: A systematic review and meta-analysis.PLoS One. 2023 Oct 24;18(10):e0286476. doi: 10.1371/journal.pone.0286476. eCollection 2023. PLoS One. 2023. PMID: 37874794 Free PMC article.
-
API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.J Assoc Physicians India. 2006 Jan;54:57-74. J Assoc Physicians India. 2006. PMID: 16649742 Review.
Cited by
-
Temporal trends from HIV diagnosis to ART initiation among adults living with HIV in the Asia-Pacific (2013-2023).AIDS Res Ther. 2025 Mar 4;22(1):29. doi: 10.1186/s12981-025-00718-8. AIDS Res Ther. 2025. PMID: 40038791 Free PMC article.
-
Treatment-naïve people living with HIV aged 50 years or older in Beijing, China, 2010-2020: joinpoint regression model analysis of surveillance data.J Int AIDS Soc. 2023 Dec;26(12):e26193. doi: 10.1002/jia2.26193. J Int AIDS Soc. 2023. PMID: 38054578 Free PMC article.
-
Factors associated with late initiation of antiretroviral therapy in Iran's HIV/AIDS surveillance data.Sci Rep. 2024 Jan 2;14(1):199. doi: 10.1038/s41598-023-50713-0. Sci Rep. 2024. PMID: 38167855 Free PMC article.
References
-
- UNAIDS. UNAIDS Data 2021 (2021). Available from: https://www.unaids.org/en/resources/documents/2021/2021_unaids_data. (Accessed June 1, 2022).
-
- WHO Guidelines Approved by the Guidelines Review Committee. Guideline on when to Start Antiretroviral Therapy and on Pre-exposure Prophylaxis for HIV. Geneva: World Health Organization (2015). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials